Skip to main content
Caplight Logo









Respiree

Respiree

Private
SingaporeHealthcare & Life Scienceshttps://www.respiree.com/

Last Round

Series A

Extension

Sep 22, 2026

Total Funding Raised

$15M

Company Overview

Respiree is a health technology company that provides an AI-powered platform and proprietary sensors for monitoring and managing cardio-respiratory health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

remote patient monitoringRPMwearable sensorscardio-respiratory monitoringhospital-at-homepredictive analyticsmedical AIclinical trialsdigital biomarkersvital sign trackingEHR integrationpatient deteriorationhealth IoTconnected carevirtual ward

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Respiree Comparables

Compare Respiree with similar companies based on industry and business-model similarity.

Respiree comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioIntelliSense
87%
Biobeat
84%
Aevice Health
84%

Respiree Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionSep 22, 2026
Series AJul 23, 2025
SeedMar 9, 2022

Key People

Founding team and executive leadership

Gurpreet Singh

Chief Executive Officer

Executive Team

Respiree Investors

Notable investors and investment history

Respiree investors
InvestorRounds
SEEDS CapitalSeries A Extension, Series A, Seed
One Six 8 VenturesSeries A Extension
We Venture CapitalSeries A Extension, Series A
Bizedge CapitalSeries A Extension
ClavystBioSeries A Extension, Series A
Greenwillow Capital ManagementConvertible Debt, Series A Extension, Series A, Seed
she1KSeries A Extension, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2026

    Raised Series A Extension round

  • Jul 23, 2025

    $12M round completed.

Respiree Filings

Explore SEC and related filing metadata, where available.

Respiree filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Respiree's valuation, stock price, and market status.

Is Respiree a public or private company?

Respiree is a private company.

What is the current stock price of Respiree?

Respiree is a private company with no public stock price. No recent secondary market data is available.

How much is Respiree worth (valuation)?

Valuation information for Respiree is not publicly available.

Can I buy Respiree stock?

Respiree shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Respiree's last funding round?

Respiree's most recent funding round was Series A on July 23, 2025.

Who are the main investors in Respiree?

Key investors in Respiree include SEEDS Capital, We Venture Capital, ClavystBio, Greenwillow Capital Management, she1K.

Will Respiree IPO soon?

No public IPO plans have been announced for Respiree.

How can I track Respiree secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Respiree's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range40
Year Founded2019
Last FundingSep 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?